Variant report
Variant | esv2653918 |
---|---|
Chromosome Location | chr4:98110206-98111718 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs528172985 | chr4:98110224-98110225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs34409955 | chr4:98110237-98110238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs530442995 | chr4:98110240-98110241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548549890 | chr4:98110249-98110250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567260117 | chr4:98110314-98110315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528064804 | chr4:98110317-98110318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs71606969 | chr4:98110354-98110355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546335134 | chr4:98110366-98110367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs72885980 | chr4:98110378-98110379 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs191811785 | chr4:98110401-98110402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116105347 | chr4:98110451-98110452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs568932366 | chr4:98110476-98110477 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183122011 | chr4:98110520-98110521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554527027 | chr4:98110524-98110525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373472796 | chr4:98110530-98110531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545330531 | chr4:98110536-98110537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs540631224 | chr4:98110586-98110587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559124382 | chr4:98110658-98110659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577403229 | chr4:98110659-98110660 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs544687704 | chr4:98110660-98110661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563098042 | chr4:98110704-98110705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560017444 | chr4:98110729-98110730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375624943 | chr4:98110886-98110887 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370217751 | chr4:98110916-98110917 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs371540492 | chr4:98110938-98110939 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56258989 | chr4:98110939-98110940 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10001846 | chr4:98110949-98110950 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4266301 | chr4:98110950-98110951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs70953054 | chr4:98110967-98110968 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs113444580 | chr4:98110970-98110971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530190775 | chr4:98110975-98110976 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78769163 | chr4:98110980-98110981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs542547548 | chr4:98110994-98110995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs187821731 | chr4:98111038-98111039 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs192562613 | chr4:98111107-98111108 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370566649 | chr4:98111110-98111111 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570874056 | chr4:98111156-98111157 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149832888 | chr4:98111159-98111160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs56031057 | chr4:98111163-98111164 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571968069 | chr4:98111185-98111186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542230420 | chr4:98111195-98111196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145806381 | chr4:98111229-98111230 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550215207 | chr4:98111273-98111274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs374174901 | chr4:98111292-98111293 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536049208 | chr4:98111297-98111298 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374870401 | chr4:98111315-98111316 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554897862 | chr4:98111341-98111342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs145825074 | chr4:98111364-98111365 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534222127 | chr4:98111407-98111408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs139660849 | chr4:98111472-98111473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 19197363 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:98109800-98110400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr4:98109800-98110400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr4:98109800-98110400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr4:98110000-98110400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
5 | chr4:98110400-98110800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr4:98110400-98111200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
7 | chr4:98110400-98114800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:98110800-98111400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
9 | chr4:98111200-98111400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
10 | chr4:98111400-98118400 | Weak transcription | HUES64 Cell Line | embryonic stem cell |